AGENUS INC (AGEN) Form 10-K Annual Reports
AGENUS INC (AGEN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AGEN
CIK: 1098972
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerGregory Stamm
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412050 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412039 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-08-05 | 4 | 0001193125-26-392937 | View SEC Doc Filr Page |
| 3 | 2026-09-15 | 2026-08-05 | 3 | 0001193125-26-392080 | View SEC Doc Filr Page |
| S-3 | 2026-09-11 | — | S-3 | 0001193125-26-389364 | View SEC Doc Filr Page |
| S-8 | 2026-09-02 | — | S-8 | 0001193125-26-380282 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-12 | 8-K | 0001193125-26-355559 | View SEC Doc Filr Page |
| 424B3 | 2026-08-17 | — | 424B3 | 0001193125-26-353143 | View SEC Doc Filr Page |
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002670 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-10 | 8-K | 0001193125-26-347518 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 | 0001193125-26-347517 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-05 | 8-K | 0001193125-26-344783 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-05 | 4 | 0001193125-26-344617 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-05 | 4 | 0001193125-26-344599 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001193125-26-340363 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001193125-26-340286 | View SEC Doc Filr Page |
| S-3 | 2026-08-07 | — | S-3 | 0001193125-26-340213 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-340007 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-339996 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-339968 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-339949 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336780 | View SEC Doc Filr Page |
| EFFECT | 2026-07-27 | — | EFFECT Filing | 9999999995-26-002467 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002164 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-20 | — | SCHEDULE 13G Filing | 0001346824-26-000195 | View SEC Doc Filr Page |